These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6489417)

  • 1. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man.
    Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 1984; 26(6):761-7. PubMed ID: 6489417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gastric pH on antidotal efficacy of activated charcoal in man.
    Olkkola KT; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):565-9. PubMed ID: 6511134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethanol and pH on the adsorption of acetaminophen (paracetamol) to high surface activated charcoal, in vitro studies.
    Hoegberg LC; Angelo HR; Christophersen AB; Christensen HR
    J Toxicol Clin Toxicol; 2002; 40(1):59-67. PubMed ID: 11990205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
    Laine K; Kivistö KT; Laakso I; Neuvonen PJ
    Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity of two forms of activated charcoal to adsorb nefopam in vitro and to reduce its toxicity in vivo.
    Neuvonen PJ; Kannisto H; Lankinen S
    J Toxicol Clin Toxicol; 1983-1984; 21(3):333-42. PubMed ID: 6676475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man.
    Neuvonen PJ; Olkkola KT; Alanen T
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):1-7. PubMed ID: 6702463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of activated charcoal on absorption of tolbutamide and valproate in man.
    Neuvonen PJ; Kannisto H; Hirvisalo EL
    Eur J Clin Pharmacol; 1983; 24(2):243-6. PubMed ID: 6404636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective gastrointestinal clearance of disopyramide in rabbits treated with activated charcoal.
    Huang JD
    J Pharm Sci; 1988 Nov; 77(11):959-62. PubMed ID: 3225758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption.
    Neuvonen PJ; Vartiainen M; Tokola O
    Eur J Clin Pharmacol; 1983; 24(4):557-62. PubMed ID: 6134626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chloroquine absorption by activated charcoal.
    Neuvonen PJ; Kivistö KT; Laine K; Pyykkö K
    Hum Exp Toxicol; 1992 Mar; 11(2):117-20. PubMed ID: 1349217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do gastric contents modify antidotal efficacy of oral activated charcoal?
    Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration.
    Laine K; Kivistö KT; Pelttari S; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):270-3. PubMed ID: 8936562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers.
    Gude AB; Hoegberg LC; Angelo HR; Christensen HR
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):406-10. PubMed ID: 20002061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo comparison of the adsorption capacity of "superactive charcoal" and fructose with activated charcoal and fructose.
    Chung DC; Murphy JE; Taylor TW
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):219-24. PubMed ID: 7109011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferrous sulfate adsorption by activated charcoal.
    Chyka PA; Butler AY; Herman MI
    Vet Hum Toxicol; 2001 Feb; 43(1):11-3. PubMed ID: 11205069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ethanol modify antidotal efficacy of oral activated charcoal studies in vitro and in experimental animals.
    Olkkola KT
    J Toxicol Clin Toxicol; 1984; 22(5):425-32. PubMed ID: 6530700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.